Elevation of macrophage-derived chemokine in eosinophilic pneumonia: a role of alveolar macrophages
-
- Manabe Kazuyoshi
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Nishioka Yasuhiko
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Kishi Jun
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Inayama Mami
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Aono Yoshinori
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Nakamura Yoichi
- Clinical Research Center for Allergy and Rheumatology, National Kochi Hospital
-
- Ogushi Fumitaka
- Clinical Research Center for Allergy and Rheumatology, National Kochi Hospital
-
- Bando Hiroyasu
- Department of Pulmonary Medicine, Tokushima Prefectural Central Hospital
-
- Tani Kenji
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
-
- Sone Saburo
- Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
この論文をさがす
説明
Macrophage-derived chemokine (MDC/CCL22) and thymus-and activation-regulated chemokine (TARC/CCL17) are ligands for CC chemokine receptor 4. Recently, TARC has been reported to play a role in the pathogenesis of idiopathic eosinophilic pneumonia (IEP). The purpose of this study was to evaluate the role of MDC in IEP and other interstitial lung diseases (ILDs). MDC and TARC in the bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent assay in patients with ILDs and healthy volunteers (HV). We also examined the expression of MDC mRNA in alveolar macrophages (AM) by real-time quantitative reverse transcriptase-polymerase chain reaction. Both MDC and TARC were detected only in BALF obtained from IEP patients. The concentration of MDC was higher than that of TARC in all cases. The level of MDC in IEP correlated with that of TARC. AM from IEP patients expressed a significantly higher amount of MDC than that from HV at the levels of protein and mRNA. MDC in BALF from IEP dramatically decreased when patients achieved remission. These findings suggest that MDC, in addition to TARC, might be involved in the pathogenesis of IEP, and AM play a role in the elevation of MDC in IEP. J. Med. Invest. 52: 85-92, February, 2005
収録刊行物
-
- The Journal of Medical Investigation
-
The Journal of Medical Investigation 52 (1-2), 85-92, 2005
国立大学法人 徳島大学医学部
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204244676736
-
- NII論文ID
- 110002261665
-
- NII書誌ID
- AA11166929
-
- ISSN
- 13496867
- 13431420
-
- PubMed
- 15751278
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可